Galantamine Hydrobromide
Overview
Galantamine Hydrobromide is an alkaloid used for the treatment of mild to moderate Alzheimer's disease and various memory impairments. It functions as a reversible competitive inhibitor of acetylcholinesterase, enhancing acetylcholine availability in the brain.
API suppliers (7)
Suppliers of Galantamine Hydrobromide evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 4 of 7 suppliers.
4 of 7 hold a GMP certificate on record in the EU or UK registers
- JUBILANT BIOSYS LTDIndia1 active DMF
- SANOCHEMIA PHARMAZEUTIKA AGAustria1 active DMF GMP on record
- DR REDDYS LABORATORIES LTD1 active DMF GMP on record
- WUHAN SHIJI PHARMACEUTICAL CO LTD
- Janssen Pharmaceutica NVBelgium GMP on record
- MACFARLAN SMITH LTD GMP on record
- SA AJINOMOTO OMNICHEM NVBelgium
Therapeutic areas
Do you supply Galantamine Hydrobromide? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.